Issue
Copyright (c) 2026 Rojin Ehsan, Mahdieh Gholami, Salar Vaseghi, Maryam Eslami, Batool Ghorbani Yekta

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.Sex-specific effects of fluoxetine on REM sleep deprivation-induced behavioral impairments and BDNF downregulation in rats
Corresponding Author(s) : Batool Ghorbani Yekta
Cellular and Molecular Biology,
Vol. 72 No. 3: Issue 3
Abstract
Rapid eye movement (REM) sleep is a critical phase in which most dreaming occurs, and its deprivation (REM SD) can lead to disturbances in mood, cognition, synaptic plasticity, and neuroplasticity-related genes such as brain-derived neurotrophic factor (BDNF). Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), is known to modulate BDNF expression, and sex-dependent variations in its effects have been suggested. This study investigated the effects of REM SD, fluoxetine, and their combination on behavioral and molecular outcomes in male and female rats. Results: Following 24 hours of REM SD, animals exhibited impaired memory, increased immobility, reduced rearing, elevated pain threshold, and decreased locomotor activity, along with reduced BDNF levels in the prefrontal cortex. Females were less sensitive to REM SD regarding pain threshold and locomotor activity. Fluoxetine administration (10 mg/kg, i.p.) reversed the effects of REM SD on immobility and rearing exclusively in females, while also mitigating locomotor deficits induced by REM SD. In both sexes, fluoxetine counteracted REM SD-induced changes in pain threshold, but only in females did it restore BDNF downregulation. In conclusion, the findings suggest sex-specific variations in the consequences of REM SD and in the therapeutic response to fluoxetine. While REM SD broadly impairs cognitive, affective, and molecular parameters, females exhibit partial resilience, particularly in pain threshold and locomotor activity. Moreover, fluoxetine demonstrates sex-dependent protective effects, especially in restoring BDNF expression and behavioral outcomes in females.
Keywords
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX